The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

25 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.EBI
Warner-Lambert
Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity.EBI
Suntory Institute For Biomedical Research
2-(2-Aryl-2-oxoethylidene)-1,2,3,4-tetrahydropyridines. Novel isomers of 1,4-dihydropyridine calcium channel blockers.EBI
Warner-Lambert
Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.EBI
TBA
Synthesis and biological activity of the calcium modulator (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.EBI
Fourth Military Medical University
 
(cis)-3-methyl-1,5-benzothiazepine-4-ones: potent analogs of the calcium channel blocker diltiazenEBI
TBA
New purines and purine analogs as modulators of multidrug resistance.EBI
Institut De Recherches Servier
Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric).EBI
Seoul National University
Asymmetric synthesis and biological evaluations of (+)- and (-)-6-dimethoxymethyl-1,4-dihydropyridine-3-carboxylic acid derivatives blocking N-type calcium channels.EBI
Ajinomoto Pharmaceuticals
Stereoselective behavior of the functional diltiazem analogue 1-[(4-chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a new L-type calcium channel blocker.EBI
Universita Degli Studi Di Perugia
L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.EBI
Universita Degli Studi Di Bologna
Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening.EBI
Universit£
The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.EBI
Ajinomoto
Simplified tetrandrine congeners as possible antihypertensive agents with a dual mechanism of action.EBI
Universidad De Chile
Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.EBI
Ajinomoto
Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke.EBI
Boehringer Ingelheim Pharma
Vasorelaxation by new hybrid compounds containing dihydropyridine and pinacidil-like moieties.EBI
National Academy of Sciences of Ukraine
Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.EBI
New York University Medical Center
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca.EBI
Shandong University
Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute